4//SEC Filing
Eclipse GP III, LLC 4
Accession 0001209191-21-009051
CIK 0001652724other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 7:57 PM ET
Size
29.7 KB
Accession
0001209191-21-009051
Insider Transaction Report
Form 4
Eclipse GP III, LLC
10% Owner
Transactions
- Conversion
Common Stock
2021-02-09+877,445→ 1,854,297 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2021-02-09−976,852→ 0 total(indirect: See footnote)→ Common Stock (976,852 underlying) - Conversion
Common Stock
2021-02-09+976,852→ 976,852 total(indirect: See footnote) - Conversion
Common Stock
2021-02-09$13.60/sh+473,729$6,442,714→ 4,183,986 total - Conversion
Common Stock
2021-02-09+3,710,257→ 3,710,257 total - Conversion
Series B Preferred Stock
2021-02-09−877,445→ 0 total(indirect: See footnote)→ Common Stock (877,445 underlying) - Conversion
Series C Preferred Stock
2021-02-09−3,710,257→ 0 total→ Common Stock (3,710,257 underlying) - Conversion
Common Stock
2021-02-09+185,512→ 2,039,809 total(indirect: See footnote) - Conversion
Series C Preferred Stock
2021-02-09−185,512→ 0 total(indirect: See footnote)→ Common Stock (185,512 underlying) - Conversion
Convertible Promissory Note
2021-02-09→ 0 totalExercise: $13.60Exp: 2022-12-11→ Common Stock (473,729 underlying)
Eclipse Ventures Fund I, L.P.
10% Owner
Transactions
- Conversion
Common Stock
2021-02-09+3,710,257→ 3,710,257 total - Conversion
Series C Preferred Stock
2021-02-09−3,710,257→ 0 total→ Common Stock (3,710,257 underlying) - Conversion
Convertible Promissory Note
2021-02-09→ 0 totalExercise: $13.60Exp: 2022-12-11→ Common Stock (473,729 underlying) - Conversion
Common Stock
2021-02-09+976,852→ 976,852 total(indirect: See footnote) - Conversion
Common Stock
2021-02-09+185,512→ 2,039,809 total(indirect: See footnote) - Conversion
Common Stock
2021-02-09$13.60/sh+473,729$6,442,714→ 4,183,986 total - Conversion
Series B Preferred Stock
2021-02-09−877,445→ 0 total(indirect: See footnote)→ Common Stock (877,445 underlying) - Conversion
Series A Preferred Stock
2021-02-09−976,852→ 0 total(indirect: See footnote)→ Common Stock (976,852 underlying) - Conversion
Series C Preferred Stock
2021-02-09−185,512→ 0 total(indirect: See footnote)→ Common Stock (185,512 underlying) - Conversion
Common Stock
2021-02-09+877,445→ 1,854,297 total(indirect: See footnote)
Eclipse Ventures GP I, LLC
10% Owner
Transactions
- Conversion
Common Stock
2021-02-09+185,512→ 2,039,809 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2021-02-09−877,445→ 0 total(indirect: See footnote)→ Common Stock (877,445 underlying) - Conversion
Series C Preferred Stock
2021-02-09−185,512→ 0 total(indirect: See footnote)→ Common Stock (185,512 underlying) - Conversion
Common Stock
2021-02-09+976,852→ 976,852 total(indirect: See footnote) - Conversion
Common Stock
2021-02-09+877,445→ 1,854,297 total(indirect: See footnote) - Conversion
Common Stock
2021-02-09+3,710,257→ 3,710,257 total - Conversion
Common Stock
2021-02-09$13.60/sh+473,729$6,442,714→ 4,183,986 total - Conversion
Series A Preferred Stock
2021-02-09−976,852→ 0 total(indirect: See footnote)→ Common Stock (976,852 underlying) - Conversion
Series C Preferred Stock
2021-02-09−3,710,257→ 0 total→ Common Stock (3,710,257 underlying) - Conversion
Convertible Promissory Note
2021-02-09→ 0 totalExercise: $13.60Exp: 2022-12-11→ Common Stock (473,729 underlying)
Eclipse Fund III, L.P.
10% Owner
Transactions
- Conversion
Convertible Promissory Note
2021-02-09→ 0 totalExercise: $13.60Exp: 2022-12-11→ Common Stock (473,729 underlying) - Conversion
Common Stock
2021-02-09+185,512→ 2,039,809 total(indirect: See footnote) - Conversion
Common Stock
2021-02-09+3,710,257→ 3,710,257 total - Conversion
Series A Preferred Stock
2021-02-09−976,852→ 0 total(indirect: See footnote)→ Common Stock (976,852 underlying) - Conversion
Common Stock
2021-02-09+877,445→ 1,854,297 total(indirect: See footnote) - Conversion
Common Stock
2021-02-09$13.60/sh+473,729$6,442,714→ 4,183,986 total - Conversion
Series C Preferred Stock
2021-02-09−185,512→ 0 total(indirect: See footnote)→ Common Stock (185,512 underlying) - Conversion
Common Stock
2021-02-09+976,852→ 976,852 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2021-02-09−877,445→ 0 total(indirect: See footnote)→ Common Stock (877,445 underlying) - Conversion
Series C Preferred Stock
2021-02-09−3,710,257→ 0 total→ Common Stock (3,710,257 underlying)
Footnotes (4)
- [F1]Each share of Series A Preferred, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock at the closing of the Issuer's initial public offering, for no additional consideration. The shares of Preferred Stock had no expiration date.
- [F2]The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.
- [F3]The securities are held directly by Eclipse Fund III, L.P. ("Eclipse III"). Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any.
- [F4]The convertible promissory note automatically converted into shares of the Issuer's Common Stock at the closing of the IPO.
Documents
Issuer
Lucira Health, Inc.
CIK 0001652724
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001763854
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 7:57 PM ET
- Size
- 29.7 KB